Is Sanjiv.Parant. overvalued or undervalued?
As of October 9, 2025, Sanjiv.Parant. is considered overvalued with a valuation grade of "expensive," reflected in its high PE ratio of 31.47 and underperformance against the Sensex, having a year-to-date return of -45.54%.
As of 9 October 2025, the valuation grade for Sanjiv.Parant. moved from very expensive to expensive, indicating a shift in perception regarding its valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 31.47, an EV to EBITDA ratio of 24.33, and a PEG ratio of 1.39, all of which suggest that the stock is trading at a premium compared to its earnings growth potential.In comparison to its peers, Sanjiv.Parant. has a higher PE ratio than Cipla, which stands at 22.68, and significantly lower than Divi's Lab, which is at 70.47. Additionally, while Sanjiv.Parant.'s EV to EBITDA ratio is 24.33, it is still more favorable than that of Mankind Pharma at 31.3. The stock has underperformed against the Sensex, with a year-to-date return of -45.54% compared to the Sensex's 5.16%, reinforcing the notion that the stock may be overvalued in the current market context.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
